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Summary
Through a poorly understood mechanism, tumors respond to radiation by secreting cytokines capable of inhibiting apoptosis
in endothelial cells, thereby diminishing treatment response by minimizing vascular damage. We reveal here that this
pathway is governed by a major angiogenesis regulator, HIF-1. Following radiotherapy, tumor reoxygenation leads to: (1)
nuclear accumulation of HIF-1 in response to reactive oxygen, and (2) enhanced translation of HIF-1-regulated transcripts
secondary to stress granule depolymerization. The resulting increase in HIF-1-regulated cytokines enhances endothelial
cell radioresistance. Inhibiting postradiation HIF-1 activation significantly increases tumor radiosensitivity as a result of
enhanced vascular destruction. These data describe novel pathways contributing significantly to our understanding of HIF-1
regulation which may be major determinants of tumor radiosensitivity, potentially having high clinical relevance.
Introduction discovery suggested that tumors actively protect themselves
from secondary radiation damage by promoting EC radioresis-
It has recently been suggested that the sensitivity of tumor tance. Based on these data, several groups have investigated
vasculature to radiation is a major determinant of overall re- the effects of combining antiangiogenic agents with radiation
sponse to radiotherapy (RT) (Garcia-Barros et al., 2003). This in order to maximize EC radiosensitivity (Geng et al., 2001; Hess
relationship is attributable to the fact that in addition to directly et al., 2001; Kozin et al., 2001; Lund et al., 2000). Though this
killing tumor cells, ionizing radiation leads to a secondary cell work has met with some success, it may be possible to further
death by destroying the tumor-feeding vasculature. As tumors enhance the efficacy of this approach. The complexity of the
are highly reliant on their vessels for survival (Folkman, 2002; mechanism allowing tumors to increase EC radioresistance may
Folkman and Shing, 1992), small degrees of vascular destruc- have initially been underestimated; it appears now that numer-
tion may translate into large-scale tumor kill (Denekamp, 1993). ous factors other than VEGF may be involved. Indeed, it has
Thus, the more radiosensitive a tumor’s vasculature, the less been demonstrated that inhibiting a diverse array of EC tyrosine
radioresistant the tumor (Camphausen and Menard, 2002). Max- kinase receptors is significantly more effective at radiosensitiz-
imizing radiation’s effects on tumor endothelium may be a pow- ing tumor vasculature than is VEGF receptor blockade alone
(Ning et al., 2002). Achieving EC radiosensitization solely byerful new treatment strategy, and there is currently much interest
in exploring how this might be done. inhibiting VEGF signaling, then, may be incompletely effective
due to redundant protective signals provided by additional cyto-An important step toward understanding how the tumor
vasculature responds to radiation came from the work of Gorski kines.
Currently, very little is known about how RT induces tumorset al. (1999), who studied the effects of radiation on expression
of a prototypical angiogenic cytokine, vascular endothelial to protect endothelial cells. VEGF secretion is clearly an impor-
tant component of the pathway, but additional cytokines mustgrowth factor (VEGF). The authors found that radiation induced
tumors to secrete VEGF, and that VEGF served to enhance also be involved, as discussed above. Ultimately, achieving
optimal EC radiosensitization may require inhibition of all vascu-endothelial cell (EC) radioresistance (Gorski et al., 1999). This
S I G N I F I C A N C E
Approximately half of all US citizens diagnosed with cancer are treated with radiotherapy. Recent discoveries suggest that the
sensitivity of a tumor’s vasculature to radiation is a major determinant of radiotherapeutic outcome. There is currently great interest
in working to enhance tumor vessel radiosensitivity, thereby maximizing secondary radiation-induced tumor death caused by
vascular destruction. However, tumors avoid this secondary damage by secreting cytokines that diminish vascular radiation damage.
We hypothesize that by understanding how this protective response is activated, we can discover an effective means of inhibiting
it. This work takes a major step toward achieving this understanding, and might eventually translate into a significant clinical benefit
by allowing optimal sensitization of tumor vasculature to conventional therapeutics including radiation.
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lar radioresistance-inducing signals. An effective way to do so were specific for changes in HRE signaling activity. Quantifica-
tion of HIF-1 reporter fluorescence intensity over time revealedmay be to block these signals at the source—to disrupt a com-
mon pathway regulating the radiation-induced secretion of that irradiation caused statistically significant (p  0.05), dose-
dependent increases in tumor HIF-1 activity when compared tothese cytokines by tumors. We hypothesize that this pathway
may depend critically on signal transduction through a factor nonirradiated controls (Figure 1D). Again, the CMV-GFP control
tumors demonstrated no changes in fluorescence intensity fol-which regulates multiple angiogenic cytokines. One such regula-
tor fitting this description is hypoxia inducible factor-1 (HIF-1). lowing any dose of radiation studied.
To determine whether the observed reporter activity dataHIF-1 is a heterodimer composed of a hypoxia-regulated 
subunit and an oxygen-independent  subunit. The HIF-1 com- were reflective of actual changes in HIF-1 signaling, we next
studied radiation’s effects on protein levels for both HIF-1 andplex is capable of binding to hypoxia regulatory elements (HREs)
in the nucleus, stimulating the expression of more than 40 down- cytokines expressed under its control. Unexpectedly, irradiation
of cultured tumor cells did not cause an increase in nuclearstream genes involved in tumor metabolism, growth, and angio-
genesis, including VEGF (Semenza, 2002). Recently, it has be- HIF-1 protein levels or HIF-1 reporter activity (Figures 2A and
2B), although it did lead to increased secretion of certain HIF-come apparent that several HIF-1-regulated genes other than
VEGF are highly active in angiogenesis, including those coding 1-regulated cytokines such as VEGF (data not shown). However,
in agreement with the window chamber studies, tissue isolatedfor eryrthropoietin (EPO) (Jaquet et al., 2002), transforming
growth factor-3 (TGF-3) (Gold et al., 2000), plasminogen acti- from irradiated flank tumors had significantly (p  0.05) higher
nuclear HIF-1 levels when compared to nonirradiated controlsvator inhibitor-1 (PAI-1) (Devy et al., 2002), and transferrin (Car-
levaro et al., 1997). Moreover, some HIF-1-regulated factors (Figure 2C). Mirroring this result, irradiated flank tumors also
demonstrated increased levels of the proangiogenic HIF-1-themselves are capable of activating potent proangiogenic pro-
teins. For instance, it has been demonstrated that VEGF induces regulated cytokines VEGF and PAI-1, as well as the indirectly
regulated bFGF (Figures 2D–2F). These results argue that radia-cells to release bioactive bFGF, proving that this highly active
angiogenic cytokine is indirectly regulated by HIF-1 (Jonca et tion causes HIF-1 upregulation in vivo but not in vitro, suggesting
that an intact tumor-host interface may be required for thisal., 1997). Highly relevant here, VEGF and bFGF are the sole
factors which have been directly shown to increase EC radiore- response to occur.
sistance (Gorski et al., 1999; Paris et al., 2001). Therefore, it
may be that HIF-1 activity has a much greater impact on the RT-induced HIF-1 activation coincides
with reoxygenationpostradiation tumor-vessel relationship than does VEGF alone.
Thus, in this work we address the question of whether HIF-1 The spatiotemporal pattern of radiation-induced HIF-1 activa-
tion, described above, is highly reminiscent of reoxygenationis involved in regulating the response of tumors to ionizing radia-
tion. We investigate whether clinically relevant courses of RT (Bussink et al., 2000; Fenton et al., 1998). Thus, we sought to
determine whether we could find direct evidence to connectactivate HIF-1 in murine and human tumor models. Additionally,
we identify molecular pathways involved which provide mecha- tumor reoxygenation with HIF-1 activation. First, mice with flank
tumors stably transfected with the fluorescent HIF-1 reporternistic links between radiation exposure and HIF-1 signaling acti-
vation. Finally, studies are carried out to determine whether were randomized to receive RT or sham-RT. 48 hr later, these
animals were injected intravenously with a perfusion markerHIF-1 activation is a crucial step in the RT-induced radioprotec-
tion of tumor vasculature. These studies have important implica- (Hoechst 33342), and the tumors were removed for analysis via
microscopy of flow cytometry (Figures 3A and 3B). Very littletions for trials aimed at combining antiangiogenic agents with
radiation and, potentially, various other treatment modalities. evidence of overlap between perfusion and HRE-GFP expres-
sion was found in sham-irradiated tumors (1.9%  0.3% dou-
ble-positive by FACS). This pattern of discordance was retainedResults
in tumors following radiation (2.0%  0.4% double-positive),
despite the overall increase in reporter signal intensity. Thus,Radiation upregulates HIF-1 levels and activity
We first investigated whether radiation upregulates tumor HIF-1 radiation-induced HIF-1 activation, like physiologic tumor HIF-1
activation, occurs in tumor cells that are distant from perfusedactivity. Tumor cell lines stably transfected with a fluorescent
reporter of HIF-1 activity were grown in skinfold window cham- vasculature.
Following irradiation, tumor oxygenation tends to increasebers. These cells express GFP under the control of an HRE
element, the DNA binding site for HIF-1, thereby allowing serial secondary to various complicated physiological responses
(Dewhirst et al., 1990). Although reperfusion may be involved,monitoring of HIF-1 activity levels by following GFP expression
(Figure 1A). Intravital fluorescence microscopy was used to re- decreased oxygen consumption by tumor cells allows for oxy-
genation to improve even in the absence of increased perfusioncord reporter activity in these tumors following irradiation (Figure
1B). During fractionated RT, HIF-1 activity decreased slightly. (Kallman, 1972). In our model, then, irradiated tumor tissue that
is distant from perfused vessels (i.e., the GFP tissue describedApproximately 12–24 hr after radiation, HIF-1 activity began to
increase steadily over time, peaking 48 hr following treatment. above) may be better oxygenated than it was before RT. To
test this hypothesis, we administered a hypoxia marker drug,Spatially, HIF-1 activation was noted first at the tumor periphery,
and migrated toward the center of the tumor between 24 and pimonidazole, 48 hr after irradiating HRE-GFP-reporting tumors.
Nonirradiated tumors demonstrated tight colocalization of GFP48 hr after treatment. As a positive control, window chamber
tumors expressing GFP independent of HIF-1 activity (CMV- and pimonidazole signals; irradiated tumors contained a sig-
nificantly smaller proportion of GFP tissue colocalizing withGFP) were also irradiated. This control group demonstrated no
changes in GFP signal intensity or expression patterns (Figure pimonidazole (Figure 3C). For sham-irradiated tumors, 91.3 
3.3% of the total GFP tumor tissue area was associated with1C), indicating that the post-RT HIF-1 reporter observations
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Figure 1. RT induces HIF-1 reporter activation
A: Representative baseline HIF-1 reporter activity in window chamber 4T1 tumors at days 1, 3, and 7 following tumor implantation. Tumors typically became
sufficiently large and vascularized for irradiation between days 12 and 14. Bar  300 m.
B: Representative post-RT HIF-1 reporter activity in window chamber 4T1 tumors. Following radiation, upregulation began at the tumor periphery, and
peaked at 48 hr post-RT. Note that vascular growth proceeds following RT, indicating an apparent radioresistance of the tumor vasculature. Bar  300 m.
C: Irradiation of window chamber 4T1 tumors constitutively expressing GFP (CMV-GFP) caused no change in fluorescence intensity.
D: Longitudinal quantification of GFP fluorescence intensity in tumors expressing HIF-1-inducible GFP (H-G) and constitutive GFP (C-G) following irradiation
with 0 Gy, 5 Gy, 10 Gy, or 15 Gy. *, p  0.05; †, p  0.005, versus non-irradiated tumors.
pimonidazole, but this association occurred for only 18.0  we hypothesized that radiation-induced tumor reoxygenation,
in vivo, might generate enough oxidative stress to stabilize0.8% of irradiated tumor tissue (Figure 3D). These results indi-
cate that the majority of HRE signaling in irradiated tumors HIF-1.
In order to investigate this hypothesis, we developed a noveloccurs in tissue with relatively high oxygenation levels. This is
contrary to the normal paradigm of HIF-1 upregulation by hyp- assay to permit serial in vivo monitoring of tumor free radicals.
Skinfold window chamber tumors were suffused with mediaoxia, making it a striking finding strongly supporting the conclu-
sion that radiation-induced HIF-1 activation coincides with tu- containing the free radical-sensitive dye carboxy-27-dihydro-
dichlorofluorescein diacetate (H2DCFDA), which is converted tomor reoxygenation.
the fluorescent DCFDA when exposed to various free radical
species. DCFDA, whose fluorescence is not free radical-respon-Free radical species link reoxygenation
sive, was used in a control group of tumors to rule out nonspe-to HIF-1 activation
cific radiation effects on dye accumulation. As a further control,Having linked radiation-induced tumor reoxygenation with HIF-1
tumors were treated after RT with a small molecular weightactivation, we next sought to understand the mechanisms con-
mimetic of superoxide dismutase (SOD) with potent catalyticnecting the two. As has been suggested by in vitro studies
(Hammond et al., 2003), reoxygenation of hypoxic tumor cells activity against a variety of free radical species (Batinic-Haberle
et al., 1998). It was reasoned that if H2DCFDA incubation re-may induce the formation of free radicals. Moreover, ROS have
been shown to be both necessary (Chandel et al., 1998) and vealed an increase in tumor ROS and RNS following RT, it
should be possible to reverse this effect with the SOD mimetic.sufficient (Chandel et al., 2000) for HIF-1 activation. Therefore,
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Figure 2. RT induces upregulation of HIF-1 and
downstream cytokines
A and B: Irradiation of tumor cell lines in vitro
caused no detectable increase in HIF-1 nuclear
levels or reporter activation at 48 hr post-RT. Data
were essentially identical at 24 and 72 hr post-
RT (not shown). Positive controls are shown for
comparison. Results were normalized to the
mean sham-treated value.
C–F: Quantification of HIF-1, VEGF, FGF, and PAI-1
protein levels in excised flank 4T1 tumors. Actual
data points shown; bar represents mean. For
HIF-1, FGF, and PAI-1, results were normalized to
the sham-treated mean values. *, p 0.05, versus
nonirradiated tumors.
Following a short RT course (two 5 Gy fractions), the free peared highly dependent on this response, we next asked
whether postradiation free radical scavenging could significantlyradical-sensitive H2DCFDA signal was seen to increase dramati-
cally over that seen before treatment (Figure 4A), while no improve radiotherapeutic tumor control. Flank tumors were ran-
domized to treatment with or without radiation, then with orchanges in the free radical-insensitive DCFDA signal intensity
were observed. When the SOD mimetic was administered fol- without SOD mimetic injection. Again, this free radical scaven-
ger was administered after the completion of RT so that interfer-lowing completion of RT, the radiation/reoxygenation-induced
H2DCFDA response was completely suppressed (Figure 4A), ence with the initial ROS induced by ionizing radiation could be
avoided. Whereas SOD mimetic administration had little impactvalidating the specificity of the assay. These results confirm,
then, that RT leads to a delayed increase in tumor oxidative on tumor growth, combining it with radiation led to significant
enhancement of tumor growth delay (Figure 4F). Together, thesestress coinciding with reoxygenation.
Next, we studied whether oxidative stress could increase results confirm the importance of free radical species, stimu-
HIF-1 levels in tumors. In agreement with previous reports lated during radiation-induced reoxygenation, in causing HIF-1
(Chandel et al., 2000), exposure of cells to 10 M H2O2 for 10 activation and vascular radioresistance.
hr caused approximately 2-fold increases in nuclear HIF-1 levels
(Figure 4B). This effect was abrogated in the presence of equi- Reoxygenation enhances translation
of downstream HIF-1 signalsmolar concentrations of the SOD mimetic. Similarly, reactive
nitrogen species generated by the NO donor NOC-18 (DETA- There is a second, free radical-independent mechanism through
which reoxygenation stimulates HIF-1 signaling. Detailed stud-NONOate) caused nuclear accumulation of HIF-1 in cultured
tumor cells (Figure 4C). Next, we asked whether scavenging ies of HIF-1 reporter constructs have revealed that exposing
hypoxia-cultured cells to a period of reoxygenation enhancestumor free radicals after RT could also suppress the stimulus
for postradiation HIF-1 accumulation in vivo. In both the flank downstream HIF-1 signaling (Vordermark et al., 2001). We hy-
pothesized that this phenomenon might account, in part, fortumor and dorsal skinfold window chamber models, antioxidant
treatment delivered after the completion of radiotherapy com- the increased expression of HIF-1-regulated genes following
radiation in vivo.pletely blocked nuclear HIF-1 upregulation and reporter gene
activation, respectively (Figures 4D and 4E). Importantly, when First, we optimized the experimental conditions to best ex-
amine the effects of hypoxia and reoxygenation on HIF-1 signal-HIF-1 was blocked in this way, dramatic destruction of the
tumor vasculature was observed, beginning shortly after the time ing in vitro. In our hands, HRE-GFP fluorescence intensity re-
mains relatively constant during exposure to hypoxia (0.5% O2)of typical peak radiation-induced HIF-1 activation (Figure 4E).
As antioxidant treatment inhibited radiation/reoxygenation- up to 18 hr—after which point the signal increases significantly
over time (Figure 5A). A 12 hr incubation at 0.5% O2, however,induced HIF-1 activation, and since the tumor vasculature ap-
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Figure 3. RT-induced HIF-1 activation coincides with reoxygenation
A: Representative tumor sections demonstrating increased GFP intensity in irradiated tumors, but lack of overlap with a perfusion marker (Hoechst) regardless
of treatment. Bar  300 m.
B: Representative data for HCT116 tumors excised and disrupted to single cells for analysis via flow cytometry. Note increased proportion of GFP-intense
counts in irradiated tumors (arrow). Approximately 2% of cells were positive for both GFP and the perfusion marker, regardless of treatment.
C: Representative pimonidazole immunohistochemistry in 4T1 tumors. Pimonidazole staining was closely associated with HRE-GFP expression in sham-treated
tumors (see Experimental Procedures). In irradiated tumors, HRE-GFP expression was frequently seen in the absence of hypoxia marker signal. Bar  50 m.
D: Quantification of immunohistochemistry staining patterns for 4T1 tumors. HRE-GFP was tightly associated with pimonidazole in nonirradiated tumors.
Following irradiation, the majority of the GFP signal was found in pimonidazole-negative tissue. *, p  0.05, versus nonirradiated tumors.
does not appreciably increase HRE-GFP fluorescence intensity hancement to proceed. Analogous results were seen for the
effects of reoxygenation on VEGF secretion in two cell linesin these cells. Therefore, we chose this time point to study,
since it would describe the effects of reoxygenation, specifically, (Figure 5D), confirming that these effects are relevant to down-
stream HIF-1 signaling in general. Of note, cells incubated aton HIF-1 signaling. Reoxygenation of hypoxic cells resulted in
a complete loss of nuclear HIF-1 within 10 min (data not shown). 0.5% O2 for longer periods of time had proportionately similar
HRE-GFP signal enhancement after reoxygenation. Reoxy-Despite the lack of nuclear signaling, however, HRE-GFP fluo-
rescence intensity was significantly enhanced during reoxygen- genating cells after exposures of 12, 24, and 48 hr at 0.5% O2
resulted in increases in fluorescence intensities of 92.862.4%,ation (Figure 5B). In contrast, reoxygenation had no impact on
CMV-GFP fluorescence intensity (Figure 5C). Since HIF-1 is not 94.44  1.8%, and 91.78  1.5%, respectively, indicating that
this response is relevant to a broad range of potential physio-found in the nucleus during reoxygenation, it would be expected
that reoxygenation enhancement of HRE-GFP signal occurs logic exposures to hypoxia.
Together, these results suggest that a protected pool ofindependently of mRNA production. Supporting this hypothesis,
transcriptional blockade with actinomycin D has no effect on HIF-1-regulated transcripts are kept untranslated until reoxy-
genation occurs, at which point robust translation of this mRNAreoxygenation-mediated enhancement HRE-GFP fluorescence
intensity. Conversely, inhibiting translation with cycloheximide takes place. Thus, we next investigated whether such a hypoxia-
inducible translational silencing mechanism might account forcompletely abrogates the response, confirming that active pro-
tein production is required for this reoxygenation-mediated en- the observed effects of radiation and reoxygenation on HIF-1
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Figure 4. Reoxygenation-induced free radical species upregulate HIF-1
A: Representative microscopy images captured following incubation of window chamber tumors with an ROS-sensitive dye (DCFA). ROS abundance
increased during reoxygenation, but was inhibited by treatment with the SOD mimetic. Bar  300 m.
B: In vitro, exposing 4T1 cells to H2O2 every 20 min for 10 hr resulted in increased nuclear HIF-1 levels, as determined by ELISA. Response was blocked with
equimolar amounts of an SOD mimetic. Results were normalized to the sham-treated mean value. *, p  0.05, versus no H2O2.
C: In vitro, incubating 4T1 cells with the nitric oxide donor DETA-NONOate (AG Scientific) for 10 hr significantly increased nuclear HIF-1 levels. Coincubation
with equimolar concentrations of an SOD mimetic inhibited this response. Results were normalized to the sham-treated mean value. *, p  0.05, versus no
nitric oxide donor.
D: Flank tumors randomized to RT (15 Gy) or sham-RT, followed by PBS or SOD mimetic, and excised 48 hr after treatment. Nuclear HIF-1 levels were assayed
via ELISA, and results were normalized to the sham-treated mean value. *, p  0.05, RT-SOD versus RT-PBS.
E: HRE-GFP reporter tumors grown in window chambers and randomized to RT (15 Gy) or sham-RT, followed by PBS or SOD mimetic, and monitored using
intravital microscopy. Note that GFP fluorescence intensity decreased at 48 hr post-RT (compare to Figure 1B), and that striking vascular destruction
occurred by 72 hr after treatment (arrow).
F: Flank tumors randomized to RT or sham-RT, followed by PBS or SOD mimetic, and followed with caliper measurements. *, p  0.05 RT-SOD versus RT-PBS
by log-rank analysis.
signaling. A stress-induced translational control mechanism— tained a dominant negative mutant of TIA-1, a key stress granule
scaffolding protein (generous gift of Dr. N. Kedersha). This mu-regulated by so-called stress granules—closely fits our hypoxia-
reoxygenation HIF-1 data. Stress granules are cytosolic poly- tant, TIA-1	RRM, lacks the RNA recognition motif of the native
protein and renders a cell incapable of forming stress granulesmers consisting of nearly half a cell’s mRNA bound to distinct
RNA shuttling proteins. These granules form in response to a (Kedersha et al., 1999). By transiently transfecting cells with this
mutant, we were able to inhibit stress granule polymerizationvariety of stressors and tightly regulate translation, allowing only
the most crucial proteins to be synthesized. Once the stress is in response to hypoxia (data not shown). Therefore, we investi-
gated whether inhibiting stress granule activity would alter HIF-1alleviated, the granules depolymerize and the surviving cell can
then recommence translation and recover appropriately (Ander- regulation during hypoxia and reoxygenation. 4T1 cells were
transiently transfected with TIA-1 or TIA-1	RRM. Cells wereson and Kedersha, 2002; Kedersha and Anderson, 2002). Al-
though stress granule polymerization had not before been de- then exposed to normoxia (21% O2, 24 hr), hypoxia (21% O2,12
hr; 0.5% O2, 12 hr), or reoxygenation (0.5% O2, 12 hr; 21% O2,scribed in response to hypoxia, our data strongly suggested
that they might be involved. Therefore, we stained hypoxia- 12 hr), and HIF-1 signaling was quantified by measuring HRE-
GFP intensity. Blocking stress granule formation with TIA-treated cells for a stress granule constituent, TIAR. This staining
revealed that stress granules formed in tumor cells following 1	RRM inhibited the usual hypoxia-mediated translational
silencing, resulting in efficient expression of HIF-1-regulatedhypoxic incubation after as little as 4 hr. Upon reoxygenation,
the granules were no longer detectable (Figure 5E). proteins during hypoxic stress (Figure 5F). With nonfunctional
stress granules, HIF-1-regulated transcripts were robustly trans-We next investigated whether stress granules specifically
inhibit the translation of HIF-1-regulated transcripts. We ob- lated during hypoxia, and reoxygenation failed to further upregu-
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Figure 5. Stress granules suppress downstream HIF-1 signaling
A: 4T1 cells expressing HIF-1-inducible GFP were exposed to 0.5% O2 for various lengths of time, and the GFP fluorescence intensity was quantified by flow
cytometry. *, p  0.05 versus normoxic control.
B: 4T1 cells expressing HRE-GFP were exposed to 24 hr of normoxia (normoxia), 12 hr of normoxia followed by 12 hr of hypoxia (hypoxia), or 12 hr of hypoxia
followed by 12 hr of normoxia (reox). During the last 12 hr of the experiment, cells were exposed to PBS, cycloheximide (1 g/ml), or actinomycin D (1 g/ml).
HRE-GFP fluorescence intensity was quantified by flow cytometry. Reoxygenation induced a translation-dependent, transcription-independent upregulation
in downstream HIF-1 activity, as quantified by flow cytometry. *, p  0.05 versus normoxic control.
C: 4T1 cells expressing CMV-GFP were treated and analyzed as in B. Reoxygenation had no impact on the fluorescence intensity of these cells.
D: 4T1 and MDA-MB231 cells were treated as in B. VEGF secretion into the media increased in a translation-dependent, transcription-independent fashion
following reoxygenation, as quantified by ELISA. *, p  0.05 versus hypoxic control.
E: 4T1 cells were exposed to hypoxia (0.5% O2) with or without reoxygenation (21% O2), followed by staining for TIAR, a stress granule component. Note the
appearance of discrete cytoplasmic granules after a four-hour hypoxic incubation, dissipating rapidly upon reoxygenation (arrows).
F: 4T1 cells expressing HRE-GFP were transfected TIA-1 or with a dominant-negative TIA-1 mutant (TIA-1	RRM) and exposed to normoxia, hypoxia, or
reoxygenation. A significant increase in the HRE-GFP reporter signal was seen during hypoxia in TIA-1	RRM-transfected cells, but during reoxygenation in
cells transfected with the wild-type TIA-1. Data are normalized to the fluorescence intensity of normoxia-incubated cells. *, p  0.05 versus wild-type control.
late HIF-1 signaling. In contrast, cells transfected with wild-type reoxygenation leads to their depolymerization. These data sup-
port the conclusion that stress granules are involved in regulat-TIA-1 displayed the typical pattern of inefficient downstream
ing hypoxic gene translation in vivo, and that their translationalHIF-1 signaling after 12 hr of hypoxia, augmented upon reoxy-
inhibition may be reversed by radiation/reoxygenation.genation. Transfecting the vector control resulted in data similar
to that seen upon transfection of wild-type TIA-1 (data not
shown). In summary, these data strongly support the conclusion HIF-1 regulates radiation-induced EC radioresistance
We next sought to determine to what degree postradiation HIF-1that reoxygenation enhances downstream HIF-1 signaling by
depolymerizing stress granules, leading to increased translation activation regulates vascular radioresistance. As shown above,
radiation upregulates the expression of two important cytokinesof HIF-1-regulated transcripts.
Finally, we sought to determine whether the same patterns partially regulated by HIF-1—VEGF and bFGF. It would be infor-
mative to know whether radiation-induced secretion of theseof stress granule formation and depolymerization in response to
hypoxia and reoxygenation, respectively, could be found in vivo. factors is regulated by HIF-1 or by a competing mechanism. If
regulated by HIF-1, their expression would be seen in the sameTIAR staining of sham-irradiated tumor sections revealed that
stress granules form in the ambient—hypoxic—tumor environ- pattern as radiation-induced HIF-1 upregulation; i.e., comple-
mentary to vascular perfusion. If regulated by an alternativement, and that they colocalize with areas of hypoxic gene activity
(Figures 6A and 6B). In line with their proposed importance in mechanism—for instance, directly induced by radiation through
MAPK signaling (Park et al., 2001)—the pattern would likely beradiation-induced HIF-1 signaling, stress granules stain much
less intensely in irradiated tumors, suggesting that radiation/ much different (i.e., diffuse upregulation throughout the tumor).
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with an MTT assay 72 hr later. Media taken from HIF-1-compe-
tent tumor cells exhibited equal EC-radioprotective effects when
the tumor cells had been exposed to normoxia, radiation, and
hypoxia, but was more potently radioprotective when taken
from cells exposed to hypoxia/reoxygenation. In contrast, the
conditioned media displayed no significant EC-radioprotective
capacity in response to hypoxia/reoxygenation when taken from
HIF-1 incompetent cells (Figure 7C). These results suggest that
hypoxia/reoxygenation induces tumor cells to secrete EC-radio-
protective cytokines through a HIF-1-dependent pathway.
The data presented above support the hypothesis that radia-
tion-induced HIF-1 activation is a vital determinant of vascular
radiosensitivity. We sought direct evidence for this hypothesis
by investigating the effects of combining radiotherapy with a
HIF-1-targeting drug, YC-1 (Yeo et al., 2003). We chose a rela-
tively low YC-1 dose (5 mg/kg), which was found to decrease
tumor HIF-1 levels, but to have minimal effects on tumor vascu-
larity or growth rate, alone (data not shown). Also, a relatively
low radiation dose (10 Gy) was chosen, which has historically
had mild effects on the growth of this tumor model (Lohr et al.,
2000). Administered after radiation, this dose of YC-1 caused
significant (p  0.01) tumor growth delay, essentially inhibiting
tumor regrowth until the drug was discontinued (Figure 8A).
Window chamber studies demonstrated that the combination
of radiation with YC-1 blocked postradiation HIF-1 upregulation,
and resulted in significant vascular destruction (Figure 8B). It
was also noted that this combination of therapeutics was selec-
tively toxic for tumor vasculature. Nearby nontumor vessels did
Figure 6. Radiation/reoxygenation destabilizes stress granules in vivo not appear to be affected by this treatment, suggesting that
A: 4T1 HRE-GFP-expressing tumors were irradiated, excised 48 hr later, and combining HIF-1 blockade with radiation may increase antitu-
stained for TIAR, a stress granule protein. Representative tri-colored sections mor efficacy without enhancing normal tissue damage.
are shown from irradiated and sham-irradiated tumors, demonstrating typi-
cal Hoechst perfusion staining (H), endogenous GFP expression (G), and
DiscussionTIAR staining (T). For nontreated tumors, TIAR staining is most intense in areas
of high HIF-1 activity. In post-RT tumors, TIAR staining is weak, although some
association with HIF-1 activity is retained. Bar  50 m. Intense research interest has stemmed from the discovery that
B: Sections were prepared as in A, followed by brief nuclear counterstaining radiation prompts tumors to promote radioresistance in their
with Hoechst and imaging at high magnification (100
). Representative
vessels, and there is interest in blocking this response to im-tricolored sections are shown from a sham-irradiated tumor. Hoechst stain
prove treatment efficacy. There are two attractive approaches(H) marks cellular nuclei, and GFP signal (G) marks the cytoplasm. TIAR stain
(T) appears granular and completely localized to the cytoplasm. Bar  for developing strategies to target RT-induced EC radioprotec-
10 m. tion. One option would be to identify in ECs the radioprotective
signals initiated by the binding of relevant cytokines. If a
common pathway were discovered, blocking this signaling in
ECs could then silence the radioprotective message, rendering
To address this issue, irradiated tumors were stained for VEGF tumor vessels more sensitive to radiation. Some previously pub-
and FGF to determine whether a particular staining pattern pre- lished work has made progress toward this goal, identifying
vailed. As shown in Figure 7A, postradiation VEGF and bFGF conserved EC signaling pathways, including Raf-1 and PI3K/
expression overlapped completely with HIF-1 reporter activity. Akt, used by important radioprotective factors such as VEGF
In fact, no staining for either cytokine was ever observed in and bFGF (Alavi et al., 2003; Edwards et al., 2002). Though
the absence of HRE-GFP expression in irradiated tumors. This this strategy has shown potential, it has important drawbacks.
finding strongly implicates radiation-induced HIF-1 upregulation Specifically, inhibiting EC survival signals would likely have an
in promoting post-RT VEGF and bFGF secretion. Since they equal radiosensitizing effect on normal and malignant tissue.
play a strong role in determining the level of EC radiosensitivity, Therefore, to achieve a therapeutic advantage, sophisticated
these data support the importance of HIF-1 in regulating radiore- mechanisms would be essential to deliver the therapy selectively
sistance of the tumor vasculature. to tumor vasculature (Hood et al., 2002).
To further explore this hypothesis, siRNA was used to de- A potentially more promising strategy may be to target the
plete tumor cells of nuclear HIF-1 by knocking down HIF-1 or radiation-induced radioprotective response at its source: the
HIF-1 (Figures 7B). These cells were then exposed to normoxia, tumor cell. Theoretically, if one were able to identify and block
radiation, hypoxia, or hypoxia followed by reoxygenation, and a step sufficiently upstream in this pathway, the EC radioprotec-
the resulting conditioned media was collected to test for radio- tive response could be inhibited before the protective cytokines
protective capacity. The conditioned media was added to irradi- were ever released. Not only would this approach achieve effi-
cient vascular radiosensitization, it would be specific for tumorated endothelial cells in culture, and EC viability was determined
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Figure 7. HIF-1 RT response regulates EC radiosensitivity
A: 4T1 HRE-GFP-expressing tumors were irradiated, excised 48 hr later, and stained for VEGF. A representative section showing Hoechst perfusion staining
(H), endogenous GFP (G), and VEGF staining (V), as well as overlay images for each. A similar section is shown stained for bFGF (F). Bar  50 m.
B: Nuclear HIF-1 levels for 4T1 cells constitutively expressing scrambled (scr), HIF-1-targeted (hif1a), or HIF-1-targeted (hif1b) siRNA. Cells were cultured for
12 hr under hypoxic (0.5% O2) or normoxic (21% O2) conditions. Both siRNA species virtually eliminate all nuclear HIF-1 accumulation. Results are normalized
to the mean HIF-1 level from the normoxia-cultured scrambled cells.
C: Conditioned media from siRNA-expressing 4T1 cells exposed to normoxia, radiation, or reoxygenation was added to irradiated ECs to test for radioprotec-
tive capacity (see Experimental Procedures). Nonconditioned media—“empty”—was used as a negative control. Reoxygenation of control tumor cells
conferred significant EC-radioprotective capacity on conditioned media, but this effect was lost when the media was conditioned by HIF-1-depleted
tumor cells. Results are expressed as the ratio of the MTT OD540 for irradiated over nonirradiated ECs. *, p  0.05 scr versus hif1a or hif1b cells.
vessels as well. For these reasons, there appears to be much especially in light of data from our studies and others (Gorski
et al., 1999; Park et al., 2001) which have demonstrated thatpromise in studying how radiation induces an EC-radioprotec-
tive response in tumors for the purpose of developing novel radiation can directly cause VEGF secretion from tumor cells
in vitro. The discrepancy forces us to consider the possibilityvascular radiosensitizers.
The work presented here takes a significant step toward that irradiation of cultured cells stimulates VEGF secretion
through an “artificial” mechanism, irrelevant to the actual biologythis goal. We were able to successfully identify a pathway which
appears to play a dominant role in regulating the tumor EC- found in irradiated tumors, in vivo. It could be speculated that
irradiation of cultured cells might cause accumulation of cyto-radioprotective response. A dual mechanism, initiated by radia-
tion-induced tumor reoxygenation, leads to significant upregula- kines in the overlying media which do not accumulate in tumor
tissue (due to degradation, transport, etc.), and that these cyto-tion of tumor HIF-1 activity. The importance of this response
was illustrated in several ways. First, it was shown that after kines might initiate an autocrine loop culminating in VEGF secre-
tion. This might explain why evidence was lacking for post-RTRT, EC-radioprotective cytokines were secreted exclusively in
concert with high HIF-1 activity. This is a subtle yet important VEGF and bFGF expression in well-perfused, well-oxygenated
tumor tissue. In either case, these immunohistochemistry datapoint. The fact that post-RT VEGF and bFGF expression colocal-
ized so strongly with HIF-1 activation weakens the case for strongly support the conclusion that HIF-1 is a major regulator
of important known EC-radioprotective cytokines.competing mechanisms regulating radiation-induced EC-radio-
protection in tumors. This was a somewhat surprising finding, Second, we demonstrated that HIF-1-regulated cytokines
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Figure 8. HIF-1 blockade enhances RT efficacy
A: Combining RT with a HIF-1-targeting therapeu-
tic significantly improved tumor growth delay
over that with either treatment alone. RT began
on day 12, and daily YC-1 injections began on
day 15 (arrow). After two weeks without progres-
sion, YC-1 was withdrawn to determine whether
regrowth would occur (arrowhead). *, p  0.05
versus RT alone by log-rank analysis.
B: Combined radiation and YC-1 treatment re-
sulted in substantial destruction of the tumor vas-
culature. Post-RT HIF-1 upregulation was inhibited
by YC-1 treatment. Regression of tumor vessels
was seen as early as 24 hr after RT, and was
prominent by 48 hr post-RT (compare to Figure
1B). Arrows highlight the apparent relative resis-
tance of nontumor vessels in the nearby irradi-
ated normal tissue.
are capable of decreasing EC radiosensitivity. Stimulating tumor apoptosis peaks 4–8 hr following RT, radiation-induced vascular
destruction typically begins 48 hr later (Geng et al., 2001). More-cells to secrete HIF-1-regulated cytokines confers an EC-radio-
over, the percentage of ECs undergoing apoptosis followingprotective capacity on tumor-conditioned media. Unexpectedly,
clinical doses of RT is usually between 0 and 8% (Edwards etdepleting cells of HIF-1 activity through knocking down HIF-
al., 2002; Garcia-Barros et al., 2003)—a change which may or1 or HIF-1 completely inhibited their ability to mobilize EC
may not be able to account for the vascular damage typicallyradioprotectors in response to hypoxia/reoxygenation. Since
seen with these doses. Along the same lines, it seems illogicalhypoxia/reoxygenation seems to be the main stimulus for the
that HIF-1 activation (occurring 40 hr after peak EC apoptosis)radioprotective response in vivo, these results would suggest
would have an effect on the vasculature; that is, unless apopto-that HIF-1 plays a dominant role in regulating the radiosensitivity
sis is not the sole significant mechanism of EC death in responseof tumor vasculature following RT.
to RT. Intriguingly, work by others has shown that combining RTThe importance of HIF-1’s dominance here was verified by
with angiostatin causes significantly enhanced EC cytotoxicitydemonstrating significantly improved tumor control when irradi-
without an accompanying increase in the levels of EC apoptosisation was combined with a HIF-1 inhibitor. YC-1, which was
(Mauceri et al., 1998). These studies, along with the data pre-capable of suppressing HIF-1 activity at low doses (5 mg/kg) in
sented above, support the concept that endothelial cells mayour hands, was potently synergistic in this study. It had dramatic
undergo significant nonapoptotic cell death in response to radia-vascular destabilizing effects on the tumor vasculature without
tion, and that the release of cytokines by tumor cells can sup-
any visible impact on the surrounding normal vessels. These
press these effects.
data support the conclusion that post-RT HIF-1 may be a major The biology unveiled here by our model aptly demonstrates
determinant of tumor radiosensitivity. an important emerging concept in HIF-1 signaling: that hypoxia
Our results also raise some interesting questions about how is only a piece of the puzzle. Upon discovering that radiation
endothelial cells respond to radiation. Although apoptosis is led to reoxygenation-associated HIF-1 upregulation, we sought
commonly induced by RT, it may not be the dominant mecha- to determine which of the potential intermediating mechanisms
nism of radiation-induced death for many cell types (Abend, accounted for this finding. We considered that post-RT HIF-1
2003). Some data supports the hypothesis that apoptosis is the upregulation might be due to radiation, reoxygenation, or reoxy-
main mechanism whereby endothelial cells die in response to genation-induced free radical formation. Followup in vitro stud-
radiation damage (Garcia-Barros et al., 2003; Paris et al., 2001). ies supported only the latter two hypotheses. Thus, we sought
However, it is difficult to reconcile these findings with some to document and understand how oxidative stress and reoxy-
genation both lead to increased activity of the HIF-1 pathway.other strong evidence in the literature. For example, though EC
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internal fluorescence control. For details, see the Supplemental Data atRecent work has shown that diverse free radical species
http://www.cancercell.org/cgi/content/full/5/5/429/DC1.have potent stabilizing effects on HIF-1 in vitro (Brune et al.,
2003; Chandel et al., 1998, 2000; Gao et al., 2002; Haddad and
Tumor models
Land, 2001; Park et al., 2003; Zhou et al., 2003). However, there Window chamber implantation was carried out on 8- to 10-week-old mice
is still a large amount of conflicting data on the topic. Especially as described previously (Dewhirst et al., 1990). For details, see the Supple-
controversial has been the role of nitric oxide in regulating HIF-1. mental Data. Unless stated otherwise, all in vivo experiments were performed
with 5 mice per group.Some early work suggested that nitric oxide exerts inhibitory
effects on HIF-1 (Adhikary et al., 2000; Huang et al., 1999), but
Tumor treatmentsseveral other studies have shown the opposite to be true (Ka-
Mice fit with window chambers were randomized to treatment groups oncesuno et al., 2003; Metzen et al., 2003; Sandau et al., 2001).
tumors reached 3 mm in diameter; mice with fat pad or flank tumors were
Recent elegant studies have somewhat clarified these discrep- randomized once tumors were 1 cm in diameter. All radiation was delivered in
ancies. (Mateo et al., 2003; Wellman et al., 2003), It has been 5 Gy fractions, with 24 hr intervals separating doses in fractionated treatment,
shown that low (physiologic) NO concentrations may block un- using a Mark IV cesium irradiator (dose rate  7 Gy/min, JL Shepherd, San
Fernando, CA). Unless otherwise noted, radiation was delivered to a totalnecessary HIF-1 activation, but high (pathologic) concentrations
dose of 15 Gy. As indicated in the text, in some instances, an SOD mimeticfacilitate its activation (Mateo et al., 2003). Also, the effects of
(AEOL-10113) or HIF-1 inhibitor (YC-1) were combined with radiation.NO on HIF-1 stability appear to be context-dependent, influ-
These drugs were administered following RT to avoid interfering with the
enced by the presence or absence of key accessory oxidative radiation dose. SOD mimetic treatments (10 mg/kg, IP) were administered
species (Wellman et al., 2003). Our studies contribute to the every 24 hr for three days (0 hr, 24 hr, 48 hr). YC-1 treatments (5 mg/kg,
debate over oxidative stress and HIF-1 by demonstrating that: IP) were administered every 24 hr for the times indicated.
(1) free radical species cause tumor HIF-1 activation in vivo,
In vivo microscopyand (2) free radical species are abundant in clinically relevant
Observations of window chamber tumors were performed daily on re-tumor treatment models. Since the free radical marker and scav-
strained, unanesthetized mice using an inverted Zeiss fluorescence micro-enger used here are both highly species-insensitive, little can
scope, and images were analyzed using Adobe Photoshop (for details, see
be learned from this study about which oxidative species might Supplemental Data).
regulate HIF-1 in vivo. Even so, this study takes a significant first
step toward validating that free radical species are important Immunohistochemistry
A hypoxia marker, pimonidazole (70 mg/kg, IP; Chemicon), and a perfusionsignaling molecules in tumors, and that they act—in certain
marker, Hoechst 33342 (1 mg/mouse, IV; Sigma), were administered 3 hrscenarios, at least—to increase HIF-1 activity. These data high-
and 30 min prior to tumor excision, respectively. Subsequent immunofluo-light the importance of continuing in vivo investigation of the
rescence was performed on frozen sections of these excised tumors (forrole of tumor free radicals in HIF-1 regulation.
details, see Supplemental Data).
This work adds yet another layer to the complexity of HIF-1
signaling—posttranscriptional silencing of HIF-1-regulated genes. Flow cytometry
Historically, three regulatory points have been recognized Hoechst 33342 (1 mg/mouse, IV; Sigma) was delivered thirty minutes prior
to removing flank and mammary tumors. Excised tumors were processedwhere HIF-1 activity might be modulated: transcription rate,
to single cell suspensions and analyzed for Hoechst and GFP using flowprotein degradation rate, and nuclear activity (Semenza, 2002).
cytometry (for details, see Supplemental Data).The data presented here make it clear, though, that HIF-1 nu-
clear signaling is not the final determinant of activity in the
Protein quantification
HIF-1 pathway. During hypoxia, HIF-1-regulated transcripts are Tumor homogenates and tissue culture samples were both used for protein
partially sequestered in stress granules, resulting in a downregu- analysis. All samples were processed using a Nuclear Extraction Kit (Active-
lation of HIF-1 signaling. Upon reoxygenation, the cell is able Motif), and all were normalized by total protein content using a Bradford-
based assay (Promega). Nuclear extract HIF-1 levels were quantified withto rapidly translate the once-sequestered HIF-1-regulated tran-
a HIF-1 ELISA kit (ActiveMotif). Crude extract VEGF levels were also assayedscripts, allowing it to recover from the hypoxic shock and pre-
using an ELISA kit (R&D Systems). PAI-1 and FGF levels were determinedpare for future insults. This is a compelling finding, as it suggests
semiquantitatively by Western blot, using a polyclonal goat anti-PAI-1 anti-that stress granules may cause hypoxia-regulated genes to be
body (SantaCruz, #sc-6642) and a polyclonal rabbit anti-FGF antibody (San-
most efficiently translated after a hypoxic exposure. What is taCruz, #sc-79), detected with HRP-conjugated donkey anti-goat or donkey
unknown is to what degree HIF-1-regulated transcripts might be anti-rabbit secondary antibodies (SantaCruz).
preferentially included or excluded from stress granules during
In vivo ROS analysishypoxia. It has been observed that certain transcripts are selec-
Wild-type 4T1 tumors were grown in window chambers and exposed totively excluded from stress granules during exposure to specific
an ROS-sensitive dye (carboxy-27-dihydrodichlorofluorescein diacetate,stressors (Collier et al., 1988; Nover et al., 1989). It would be
H2DCFDA, Molecular Probes) or an ROS-insensitive dye (carboxy-27-interesting to know, then, which of HIF-1’s target gene mRNAs dichlorofluorescein diacetate, DCFDA, Molecular Probes). Mice were anes-
are efficiently translated during hypoxia and which require re- thetized, and the dye (10 M) was suffused over tumor tissue for 30 min.
oxygenation for full activity. This question also merits further After washing with saline, the cover glass was replaced, and the dichloroflu-
orescein signal was detected using intravital microscopy, as describedinvestigation.
above.
Experimental procedures
Stress granule assays
For visualization of stress granules, cells were plated on poly-L-lysine-treatedReporter construct
A HIF-1-inducible fluorescent reporter construct was created by splicing coverslips, exposed to hypoxia (0.5% oxygen), and stained with a goat
polyclonal anti-TIAR antibody (SantaCruz). To inhibit stress granule forma-five copies of the hypoxia regulatory element (HRE) upstream of enhanced
green fluorescent protein (GFP). Along with this construct, a constitutive tion, 4T1 cells stably transfected with the HIF-1 reporter were transiently
cotransfected with TIA-1/CMV-RFP, or TIA-1	RRM/CMV-RFP at a 10-to-1RFP expression vector was transduced into target cells to serve as an
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human squamous cell carcinoma xenograft tumor line. Radiat. Res. 153,ratio using Lipofectamine 2000 (Invitrogen). After a 24 hr recovery period,
398–404.the cells were incubated under normoxic or hypoxic conditions for the times
indicated, and analyzed using flow cytometry. Positive transfectants were Camphausen, K., and Menard, C. (2002). Angiogenesis inhibitors and radio-
identified by RFP fluorescence intensity greater than 99% over that of non- therapy of primary tumours. Expert Opin. Biol. Ther. 2, 477–481.
transfected controls. Cells were then analyzed for GFP intensity to determine
Carlevaro, M.F., Albini, A., Ribatti, D., Gentili, C., Benelli, R., Cermelli, S.,HIF-1 reporter activity.
Cancedda, R., and Cancedda, F.D. (1997). Transferrin promotes endothelial
cell migration and invasion: implication in cartilage neovascularization. J.siRNA constructs
Cell Biol. 136, 1375–1384.A retroviral siRNA expression vector (pSuper.retro, Oligoengine) was used
to stably introduce the following target siRNA sequences to 4T1 cells: AGAG Chandel, N.S., Maltepe, E., Goldwasser, E., Mathieu, C.E., Simon, M.C.,
GTGGATATGTCTGGG (HIF-1), AATGACATCAGATGTACCA (HIF-1), and Schumacker, P.T. (1998). Mitochondrial reactive oxygen species trigger
GGGTCTGTATAGGTGGAGA (scramble). Transductants were selected with hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95, 11715–11720.
puromycin (2 g/ml).
Chandel, N.S., McClintock, D.S., Feliciano, C.E., Wood, T.M., Melendez, J.A.,
Rodriguez, A.M., and Schumacker, P.T. (2000). Reactive oxygen speciesEC viability assay
generated at mitochondrial complex III stabilize hypoxia-inducible factor-6-well plates were seeded with 105 siRNA-expressing 4T1 cells covered with
1alpha during hypoxia: A mechanism of O2 sensing. J. Biol. Chem. 275,growth media. 12 hr later, the plates were randomized to: (1) 24 hr normoxia,
25130–25138.
(2) 10 Gy radiation, followed by 24 hr normoxia, (3) 12 hr hypoxia followed
by 12 hr normoxia, or (4) 12 hr normoxia followed by 12 hr hypoxia. Simulta- Collier, N.C., Heuser, J., Levy, M.A., and Schlesinger, M.J. (1988). Ultrastruc-
neously, 96-well plates were seeded with 103 SVEC cells in growth media. tural and biochemical analysis of the stress granule in chicken embryo fibro-
blasts. J. Cell Biol. 106, 1131–1139.24 hr later, the ECs were irradiated (10 Gy), and the growth media was
immediately replaced with either tumor-conditioned media or fresh growth
Denekamp, J. (1993). Review article: Angiogenesis, neovascular proliferation
media. 72 hr later, 1 mg/ml MTT (Sigma) was added to the EC media. 4 hr
and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol.
later, the MTT crystals were dissolved in DMSO, and read on a spectropho- 66, 181–196.
tometer at OD540.
Devy, L., Blacher, S., Grignet-Debrus, C., Bajou, K., Masson, V., Gerard,
R.D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P.J., et al. (2002). TheStatistics
pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is doseUnless otherwise noted, data are reported as a mean standard deviations.
dependent. FASEB J. 16, 147–154.Statistical significance was determined using a Student’s t test or ANOVA,
where appropriate, and p values less than 0.05 were considered significant. Dewhirst, M.W., Oliver, R., Tso, C.Y., Gustafson, C., Secomb, T., and Gross,
J.F. (1990). Heterogeneity in tumor microvascular response to radiation. Int.
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